Literature DB >> 11063804

Mutational analysis of the NM23.H1 gene in human breast cancer.

G Cipollini1, A Moretti, C Ghimenti, P Viacava, G Bevilacqua, M A Caligo.   

Abstract

NM23.H1 is a protein connected with tumor progression. Loss of heterozygosity and reduced expression of the gene have been associated with poor prognosis and increased incidence of metastases in many epithelial tumors. The aim of this study was to detect the presence of NM23.H1 point mutations or small deletions in human breast carcinomas by using the single-strand-conformation polymorphism (SSCP) technique. Mutational analysis was performed on 76 breast tumors, 10 of which had allelic deletion of the gene. The NM23.H1 mRNA content also was evaluated in each sample. Only a C-to-A transversion leading to a stop codon was found in the 5' untranslated region of exon 1. A polymorphic SSCP pattern was identified in exon 1; direct sequencing showed a C-to-T transition 30 nucleotides upstream from the 5' splice site flanking exon 1. None of the tumors analyzed presented both alleles inactivated. Our results suggest that NM23.H1 is rarely inactivated by point mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063804     DOI: 10.1016/s0165-4608(00)00250-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.

Authors:  Ju-Han Lee; Su Jin Cho; Xianglan Zhang; Zhenlong Zheng; Eung Seok Lee; Aeree Kim; Young-Sik Kim; Yang-Seok Chae; Insun Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

2.  The expression of BRCA1, P53, KAI1, and Nm23 in ovaries of BRCA1 mutation carriers after prophylactic adnexectomy.

Authors:  J Markowska; J Bar; R Mądry; I Słomska; M Mardas; J P Grabowski
Journal:  Arch Gynecol Obstet       Date:  2013-04-04       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.